This study examines risk factors for corneal endothelial cell density (ECD) loss after Baerveldt glaucoma implant insertion.

Researchers compared corneal endothelium damage after Ahmed glaucoma valve implantation with anterior chamber or ciliary sulcus placement.

Dr. Peter Andreas Netland demonstrates how treatment of neovascular glaucoma depends upon the etiology, the stage of the disease, the visual potential, and other individual patient factors.

Dr. Ramesh Ayyala explains the techniques used in endocyclophotocoagulation for glaucoma and addresses the indications for and papers written about the procedure.

In this video, Dr. Sunita Radhakrishnan discusses the ZAP and EAGLE trials regarding the use of iridotomy for primary angle closure.

Dr. Lola Idowu reviews outcomes from the PIVOTAL trial, which evaluated the safety and effectiveness of the iStent Inject, an ab interno implanted trabecular micro-bypass system, in combination with cataract surgery.

Dr. Rishi Singh discusses how pars plana glaucoma drainage implants can provide long-term IOP control and can be useful in cases with comorbidity diseases of retina and glaucoma nature, or with patients who have multiple failed anterior chamber tubes.

Dr. Patrick Gooi discusses assessing the patency of the post-trabeculectomy outflow system and using conventional ab interno canaloplasty (ABiC) or trypan blue ABiC venography to decide whether to perform inferior hemi-gonioscopy-assisted transluminal trabeculotomy (GATT), superior hemi-GATT, or full 360-degree GATT.

In this presentation, Dr. Andrew Chen describes why he would recommend surgery for the glaucoma patient with moderate glaucoma with nonadherence to topical medications and with failed selective laser trabeculoplasty (SLT).